Although obesity is now recognized as an increasingly important cause of cancer in the United States and worldwide, no medications have been proven to lower the cancer risk associated with obesity, said lead investigator Lucas Mavromatis, ScB, a medical student at the New York University Grossman School of Medicine, in an ASCO news release
For rheumatoid arthritis, they are not replacements for your DMARD or biologic but the 2025 research from centers like UCLA suggests they can be a powerful complement: less disease activity, fewer flares, lower inflammation markers, better cholesterol and blood sugar, and reduced cardiovascular risk sometimes even at low doses
Starting injections without a proper diagnosis is just guessing, and it could end up hiding other serious health issues
Eylea is indicated for the treatment of ophthalmic conditions, such as neovascular age-related macular degeneration (wet AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME) and diabetic retinopathy
New results from the Regeneron Phase 2 COURAGE trial, led by Julio Rosenstock, MD, at Velocitys site in Dallas, TX, point to a potential solution